Workflow
NightHawk Biosciences(NHWK)
icon
Search documents
NightHawk Biosciences(NHWK) - 2025 Q2 - Quarterly Report
2026-01-12 21:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-35994 Scorpius Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended J ...
NightHawk Biosciences(NHWK) - 2025 Q1 - Quarterly Report
2025-08-22 20:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-35994 Scorpius Holdings, Inc. (Exact name of registrant as specified in its c ...
NightHawk Biosciences(NHWK) - 2025 Q1 - Quarterly Results
2025-05-01 20:21
[Filing Information](index=1&type=section&id=Filing%20Information) This section details Scorpius Holdings, Inc.'s core identification and its securities registered on the NYSE American LLC [Registrant Details](index=1&type=section&id=Registrant%20Details) This section provides Scorpius Holdings, Inc.'s core identification details, including incorporation state and principal executive offices - Registrant Name: **Scorpius Holdings, Inc.**[2](index=2&type=chunk) - State of Incorporation: **Delaware**[2](index=2&type=chunk) - Principal Executive Offices: **1305 E. Houston Street, Building 2, San Antonio, TX 78205**[2](index=2&type=chunk) [Securities Information](index=1&type=section&id=Securities%20Information) The company's common stock and purchase rights are registered on the NYSE American LLC, with common stock trading under SCPX Securities Registered | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :------------------------- | :---------------- | :---------------------------------------- | | Common Stock, $0.0002 par value per share | SCPX | NYSE American LLC | | Common Stock Purchase Rights | | NYSE American LLC | [Item 2.02 Results of Operations and Financial Condition](index=2&type=section&id=Item%202.02%20Results%20of%20Operations%20and%20Financial%20Condition) Scorpius Holdings, Inc. released fiscal year 2024 financial results on April 30, 2025, with a disclaimer on its 'filed' status - On **April 30, 2025**, Scorpius Holdings, Inc. issued a press release with financial information for fiscal year ended **December 31, 2024**[5](index=5&type=chunk) - The press release is attached as **Exhibit 99.1** to this Current Report on Form 8-K[5](index=5&type=chunk) - Information in Item 2.02 and Exhibit 99.1 is not deemed 'filed' for Section 18 of the Securities Exchange Act or Sections 11 and 12(a)(2) of the Securities Act[6](index=6&type=chunk) [Item 9.01 Financial Statements and Exhibits](index=2&type=section&id=Item%209.01%20Financial%20Statements%20and%20Exhibits) This section lists the Form 8-K exhibits, including the fiscal year 2024 financial results press release and interactive data Exhibits Filed | Exhibit Number | Description | | :------------- | :----------------------------------------------------------------------- | | 99.1 | Press Release issued by Scorpius Holdings, Inc. dated April 30, 2025 | | 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101) | [Signatures](index=3&type=section&id=SIGNATURES) The report was signed on May 1, 2025, by Jeffrey Wolf, Chairman, President, and CEO of Scorpius Holdings, Inc. - The report was signed on **May 1, 2025**[10](index=10&type=chunk) - Signed by **Jeffrey Wolf**, Chairman, President, and Chief Executive Officer of Scorpius Holdings, Inc.[10](index=10&type=chunk)
NightHawk Biosciences(NHWK) - 2024 Q4 - Annual Report
2025-04-30 20:01
FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 For the transition period from ____________ to ____________ Commission file number: 001-35994 Scorpius Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 26-2844103 (Stat ...
NightHawk Biosciences(NHWK) - Prospectus(update)
2024-08-01 01:24
As filed with the Securities and Exchange Commission on July 31, 2024. Registration Number 333-280887 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 2834 26-2844103 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification N ...
NightHawk Biosciences(NHWK) - Prospectus
2024-07-18 22:36
FORM S-1 As filed with the Securities and Exchange Commission on July 18, 2024. Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 26-2844103 (I.R.S. Employer Identification No.) 627 Davis Drive, S ...
NightHawk Biosciences(NHWK) - 2024 Q1 - Quarterly Results
2024-05-29 11:14
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 29, 2024 Scorpius Holdings, Inc. (Exact name of registrant as specified in charter) (919) 240-7133 (Registrant's telephone number including area code) N/A (Former Name and Former Address) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing ...
NightHawk Biosciences(NHWK) - 2024 Q1 - Quarterly Report
2024-05-28 21:28
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______________ to _______________ Commission file number: 001-35994 Scorpius Holdings, Inc. (Exact name of registrant as specified in its c ...
NightHawk Biosciences(NHWK) - Prospectus(update)
2024-05-13 10:29
As filed with the Securities and Exchange Commission on May 13, 2024. Registration Number 333-279092 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 26-2844103 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification ...
NightHawk Biosciences(NHWK) - Prospectus
2024-05-03 11:18
As filed with the Securities and Exchange Commission on May 3, 2024. Registration Number 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SCORPIUS HOLDINGS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 26-2844103 (I.R.S. Employer Identification No.) 627 Davis Drive, Sui ...